Exploring the Impact of Cognitive Reserve on Cognitive Resilience

Aging

July 20, 2023
In a new editorial, researchers discuss their recent study investigating the effect that cognitive reserve has on brain integrity and cognitive resilience. continue reading »

Targeting Ras in Cancer Therapies: Advances in Protein Engineering

Oncotarget

July 14, 2023
In a new review, researchers from The Hebrew University of Jerusalem discuss the challenges associated with targeting Ras proteins and how protein engineering has emerged as a promising method to overcome these challenges. continue reading »

The Memtrax Continuous Recognition Test for Advanced Cognitive Impairment Screening

Aging

July 13, 2023
PRESS RELEASE: A new editorial paper was published in Aging's Volume 15, Issue 12, entitled, “Advancing screening for cognitive impairment: the memtrax continuous recognition test.” continue reading »

Cetuximab’s Effectiveness and Toxicity in Advanced Cutaneous Squamous Cell Skin Cancer

News

July 12, 2023
PRESS RELEASE: On July 7, 2023, a new research paper was published in Oncotarget, entitled, “Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series.” continue reading »

Novel GEM Model Unveils PLK1’s Role in Tumorigenesis

Oncotarget

June 29, 2023
In a new editorial, researchers discuss a study using their team’s new genetically engineered mouse (GEM) model to assess PLK1 as a driver of oncogenic transformation. continue reading »